Results 291 to 300 of about 261,254 (319)

Macrophage Activation Syndrome as an Atypical Manifestation of Mixed Connective Tissue Disease in a 14-Year-Old Girl: A Case Report. [PDF]

Cureus
Yamaoka H, Hada I, Watanabe M, Kurayama R, Yan K.   +4 more
europepmc   +1 more source

Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. [PDF]

Rheumatology (Oxford)
Baldo F, Erkens RGA, Mizuta M, Rogani G, Lucioni F, Bracaglia C, Foell D, Gattorno M, Jelusic M, Anton J, Brogan P, Canna S, Chandrakasan S, Cron RQ, De Benedetti F, Grom A, Heshin-Bekenstein M, Horne A, Khubchandani R, Ozen S, Quartier P, Ravelli A, Shimizu M, Schulert G, Scott C, Sinha R, Ruperto N, Swart JF, Vastert S, Minoia F, PReS MAS/sJIA Working Party and Paediatric Rheumatology International Trial Organization.   +30 more
europepmc   +1 more source

Development of Preliminary Criteria of Macrophage Activation Syndrome in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children. [PDF]

Biomedicines
Avrusin IS, Bregel LV, Efremova OS, Kostik MM.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MACROPHAGE ACTIVATION SYNDROME

Journal of Clinical Gastroenterology, 2011
We recently treated a patient with adult-onset Still's disease who developed macrophage activation syndrome (MAS) secondary to disseminated histoplasmosis while being treated with adalimumab. The gastroenterology service was consulted early, before diagnosis, as the patient presented with elevated liver enzymes and disseminated intravascular ...
Bijal A, Jayakar, Philip J, Hashkes
openaire   +3 more sources

Macrophage Activation Syndrome

Arthritis & Rheumatology
Macrophage activation syndrome (MAS) is a state of immune hyperactivation that can result in life‐threatening multisystem end‐organ dysfunction. Often termed a “cytokine storm,” MAS occurs among the rheumatic diseases most typically in Still's disease but also in systemic lupus erythematosus and Kawasaki disease.
Sonia Iosim, Lauren A. Henderson
  +5 more sources

Macrophage activation syndrome in pediatrics

Pediatric Allergy and Immunology, 2020
AbstractMacrophage activation syndrome (MAS) is a serious, potentially life‐threatening, hyperinflammatory condition, which belongs to the spectrum of hemophagocytic lymphohistiocytosis (HLH) and can complicate several immunologic and rheumatic disorders.
Alongi, Alessandra, Naddei, Roberta, De Miglio, Laura, Natoli, Valentina, Ravelli, Angelo   +4 more
openaire   +3 more sources

Macrophage activation syndrome

Current Opinion in Rheumatology, 2002
Macrophage activation syndrome (MAS) is a serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T lymphocytes and macrophages. Recent findings in hemophagocytic lymphohistiocytosis, a disease that is clinically similar to MAS, highlight the possible pathogenetic role ...
openaire   +3 more sources

Macrophage activation syndrome in malaria

Rheumatology International, 2009
Macrophage activation syndrome (MAS) is a clinical syndrome caused by an excessive proliferation of T lymphocytes and well-differentiated macrophages; an entity distinct from malignant histiocytosis. Although rheumatologic conditions are the common cause of MAS, a wide range of infections are also seen to cause MAS.
Rashna, Dass, Himesh, Barman, Sourabh Gohain, Duwarah, Vivek, Choudhury, Pankaj, Jain, Nayan Mani, Deka, Manjula, Murari   +6 more
openaire   +2 more sources

The genetics of macrophage activation syndrome

Genes & Immunity, 2020
Macrophage activation syndrome (MAS), or secondary hemophagocytic lymphohistiocytosis (HLH), is a cytokine storm syndrome associated with multi-organ system dysfunction and high mortality rates. Laboratory and clinical features resemble primary HLH, which arises in infancy (1 in 50,000 live births) from homozygous mutations in various genes critical to
Grant S, Schulert, Randy Q, Cron
openaire   +2 more sources